Compared with MA, MA2 has a better cell penetration, significantly increased m6A methylation in cells, suppresses glioblastoma progression, and prolongs the lifespan of GSC-grafted animals (Huang et al., 2015; Cui et al., 2017). The gene discussed is PNMA2; the disease is glioblastoma.